Top
SLC26A9 has not been detected as a mutational cancer driver

SLC26A9
Ensembl id ENSG00000174502
Mutated samples
Coding Sequence 83 (1.2%)
Protein Affecting 63 (0.9%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all SLC26A9 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 35 28 7.59
Breast carcinoma No 7 7 0.61
Uterine corpus endometrioid carcinoma No 8 5 2.17
Head and neck squamous cell carcinoma No 6 5 1.33
Bladder carcinoma No 4 4 4.08
Lung adenocarcinoma No 3 3 0.77
Colorectal adenocarcinoma No 3 3 1.31
Neuroblastoma No 2 2 0.95
Prostate adenocarcinoma No 1 1 0.41
Thyroid carcinoma No 2 1 0.31
Serous ovarian adenocarcinoma No 1 1 0.32
Stomach adenocarcinoma No 2 1 0.62
Small cell lung carcinoma No 1 1 1.45
Glioblastoma multiforme No 2 1 0.26
Medulloblastoma No 1 0 0.00
Lung squamous cell carcinoma No 1 0 0.00
Chronic lymphocytic leukemia No 2 0 0.00
Lower grade glioma No 1 0 0.00
Esophageal carcinoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence